Bio Path Holdings Inc expected to post a loss of 39 cents a share - Earnings Preview

Bio Path Holdings

11/08/2021 12:00

* Bio Path Holdings Inc  BPTH.OQ   BPTH.O  is expected to show a
no change in quarterly revenue when it reports results on August
13. 
​* Refinitiv's mean analyst estimate for Bio Path Holdings Inc
is for a loss of 39 cents per share. For the same quarter last
year, the company reported a loss of 55 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Bio Path
Holdings Inc is $12.5​, about 45.8% above​ its last closing
price of $6.78. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.49       -0.49      -0.43     Beat    13.1
 Dec. 31 2020  -0.78       -0.78      -0.57     Beat    26.9
 Sep. 30 2020  -0.83       -0.83      -0.80     Beat    3.6​
 Jun. 30 2020  -0.89       -0.89      -0.55     Beat    38.2
 Mar.          ​           -0.67      -0.90     Missed  -34.3​
 31​ 2020​                                              
 Dec. 31 2019  -0.69       -0.69      -0.73     Missed  -5.8​
 Sep. 30 2019  -0.74       -0.74      -0.78     Missed  -5.4
 Jun. 30 2019  -0.60       -0.60      -0.87     Missed  -45
 This summary was machine generated August 11 at 11:00 GMT.  All
figures in US dollars unless otherwise stated